Cannabis Law Report

JULY 23, 2019

Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

JUNE 4, 2021

We believe there is a benefit to Delta-8 but there should be labeling or warnings on packages so that consumers are informed of potential minor intoxication effects. Based on the way it’s produced, Delta 8-THC should be batch tested to ensure consumer safety. Regulations must be drafted in a way to prioritize public safety.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

SEPTEMBER 3, 2019

Andrew Cormack, Head of Production , brings considerable senior experience from GMP pharmaceutical, nutraceutical and food companies, having managed product launches, facility buildouts and large workforces to achieve quality, cost and safety targets.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. CBD and alcohol safety.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . These are the responsibility of the manufacturer. Setting Standards for Cannabis Research Studies .

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

NOVEMBER 10, 2021

as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. The NIH has contracted with a clinical research organization to conduct additional pre-clinical efficacy studies and procured a device to be used with the manufactured GMP drug product for preclinical and clinical studies.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

DECEMBER 22, 2021

We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. It has the – you assume safety, at least to a certain level. Well, I think that we can build a wonderful booming adult use consumer packaged goods market.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Some of the regulatory controls include limits on THC, packaging and labeling requirements, and products that cannot be combined with THC (e.g., Many of these are meant to address public safety risks, especially for young people.

Law 40

Law Seed-To-Sale Hemp Recreational 40